iPath Return on Disability ETN
RODI
RODI was delisted on the 20th of December, 2022.
3 hedge funds and large institutions have $25.6M invested in iPath Return on Disability ETN in 2016 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 0 closing their positions.
50% more funds holding
Funds holding: 2 → 3 (+1)
0% more capital invested
Capital invested by funds: $25.5M → $25.6M (+$105K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$164 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Barclays
London,
United Kingdom
| $25.6M | – | – | – |
|
|
2
UBS Group
Zurich,
Switzerland
| – | +$164 | +3 | New |
|
RODI Hedge Fund Activity: Q2 2016 in Review
3 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in iPath Return on Disability ETN (RODI) for Q2 2016, worth a combined $25.6M — up 0.41% from $25.5M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new RODI positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $164.
- 3 institutional investors held iPath Return on Disability ETN (RODI) as of Q2 2016, up from 2 in Q1 2016.
- Funds reported $25.6M of iPath Return on Disability ETN stock for Q2 2016, up 0.41% quarter-over-quarter.
- 1 fund opened new iPath Return on Disability ETN positions in Q2 2016 and 0 closed out, a net change of +1 holder.
- The largest iPath Return on Disability ETN buyer in Q2 2016 was UBS Group, an estimated $164 added.
Based on aggregated 13F filings for Q2 2016.